GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
59.13
+1.06 (1.83%)
At close: Feb 27, 2026, 4:00 PM EST
59.35
+0.22 (0.37%)
After-hours: Feb 27, 2026, 7:02 PM EST
GSK Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for GSK.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GSK stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 2 | 2 | 2 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Jan 6, 2026 |
| Jefferies | Jefferies | Hold → Strong Buy Initiates n/a | Hold → Strong Buy | Initiates | n/a | n/a | Oct 27, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 31, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 8, 2024 |
Financial Forecast
Revenue This Year
34.87B
from 32.67B
Increased by 6.75%
Revenue Next Year
36.57B
from 34.87B
Increased by 4.88%
EPS This Year
1.87
from 1.39
Increased by 34.76%
EPS Next Year
2.03
from 1.87
Increased by 8.58%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 37.5B | 41.4B | |||
| Avg | 34.9B | 36.6B | |||
| Low | 32.3B | 33.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.7% | 18.6% | |||
| Avg | 6.8% | 4.9% | |||
| Low | -1.1% | -2.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.07 | 2.44 | |||
| Avg | 1.87 | 2.03 | |||
| Low | 1.58 | 1.69 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 49.1% | 30.5% | |||
| Avg | 34.8% | 8.6% | |||
| Low | 13.5% | -9.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.